GeraClinic / NHS cancer waiting times / NHS Gloucestershire ICB / Cancer Screening
NHS Gloucestershire ICB: Cancer Screening — 62-Day Cancer Waits
In April 2026, 67.9% of cancer screening cancer patients in NHS Gloucestershire ICB started treatment within 62 days — 28 patients on this pathway. NHS target: 85%. Official NHS England data.
What is the Cancer Screening cancer waiting time in NHS Gloucestershire ICB?
As of April 2026, 67.9% of cancer screening cancer patients in NHS Gloucestershire ICB started treatment within 62 days of referral (19 of 28 patients, NHS target: 85%), per NHS England Cancer Waiting Times data published June 2026. Gera re-dates this monthly.
| Measure | Value | Context |
|---|---|---|
| Patients on pathway | 28 | April 2026 |
| Within 62 days | 19 | Started treatment in time |
| Breaches | 9 | Did not meet 62-day standard |
| 62-day standard met | 67.9% | NHS target: 85% |
| Status vs target | MISSED | Target is 85% |
Other cancer pathways in NHS Gloucestershire ICB
NHS Gloucestershire ICB Screening cancer waits: FAQs
- What is the 62-day cancer waiting time for Cancer Screening in NHS Gloucestershire ICB?
- In April 2026, 67.9% of cancer screening cancer patients in NHS Gloucestershire ICB started treatment within 62 days of referral — covering 28 patients (19 within standard, 9 breaches). NHS target: 85%. Data: NHS England Cancer Waiting Times, June 2026.
- What does the Cancer Screening pathway mean?
- The Screening pathway covers patients referred from NHS cancer screening programmes (breast, bowel, cervical). The 62-day clock starts from the date the screening programme refers the patient for further investigation.
- How does NHS Gloucestershire ICB's Screening performance compare to England?
- The England average for the 62-day Cancer Screening pathway was not separately published at England level in the April 2026 extract. NHS Gloucestershire ICB's 67.9% performance can be compared against the overall England 62-day combined standard met rate and the NHS 85% target.
- What counts as a breach of the 62-day cancer standard?
- A breach occurs when a patient does not start their first definitive cancer treatment within 62 days of the relevant referral date (2-week wait, upgrade, screening referral, or breast symptomatic). In NHS Gloucestershire ICB for the Cancer Screening pathway in April 2026, there were 9 breaches out of 28 patients.
Screening cancer waits in NHS Gloucestershire ICB — below NHS target
Only 67.9% of cancer screening patients in NHS Gloucestershire ICB met the 62-day standard in April 2026 (target: 85%). GeraClinic can connect you to a UK-registered cancer specialist while you await NHS assessment — your referral is not affected.
Contains public sector information published by NHS England and licensed under the Open Government Licence v3.0. Data: Cancer Waiting Times CRS Database, April 2026. Methodology.